INTELLIGENT BIO SOLUTIONS INC. Investing Cash Flow
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Investing Cash Flow of -$85.57 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $12.90K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$28.07K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$70.40K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for fiscal 2026 was -$85.57K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for fiscal 2025 was -$231.84K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for fiscal 2024 was -$221.43K.
- INTELLIGENT BIO SOLUTIONS INC. net cash provided by (used in) investing activities for fiscal 2023 was -$694.14K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $12.90K derived: sum of 2 quarters · filed 2026-08-19 | -$15.17K derived: sum of 3 quarters · filed 2026-08-19 | -$85.57K 10-K · filed 2026-08-19 |
| 2026-03-31 | $12.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$15.17K derived: sum of 2 quarters · filed 2026-05-13 | -$85.57K 10-Q · filed 2026-05-13 | -$294.09K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$28.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$98.47K 10-Q · filed 2026-02-12 | -$306.99K derived: sum of 3 quarters · filed 2026-08-19 | -$321.38K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$70.40K 10-Q · filed 2025-11-12 | -$278.92K derived: sum of 2 quarters · filed 2026-08-19 | -$293.30K derived: sum of 3 quarters · filed 2026-08-19 | |
| 2025-06-30 | -$208.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$222.90K derived: sum of 2 quarters · filed 2026-08-19 | -$231.84K 10-K · filed 2026-08-19 | |
| 2025-03-31 | -$14.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$23.32K 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | -$8.94K 10-Q · filed 2026-02-12 | |||
| 2024-06-30 | -$167.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$164.76K derived: sum of 2 quarters · filed 2025-08-15 | -$221.43K 10-K · filed 2025-08-15 | |
| 2024-03-31 | $2.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$54.12K 10-Q · filed 2025-05-13 | ||
| 2023-12-31 | -$56.67K 10-Q · filed 2025-02-13 | |||
| 2023-06-30 | -$181.75K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$7.95K derived: sum of 2 quarters · filed 2024-09-18 | -$219.25K derived: sum of 3 quarters · filed 2024-09-18 | -$694.14K 10-K · filed 2024-09-18 |
| 2023-03-31 | $173.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | -$37.50K derived: sum of 2 quarters · filed 2024-05-08 | -$512.39K 10-Q · filed 2024-05-08 | -$1.22M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$211.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$686.20K 10-Q · filed 2024-02-09 | -$1.39M derived: sum of 3 quarters · filed 2024-02-09 | |
| 2022-09-30 | -$474.89K 10-Q · filed 2023-11-08 | -$1.18M derived: sum of 2 quarters · filed 2023-11-08 | ||
| 2022-06-30 | -$703.01K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$880.22K 10-K · filed 2023-08-23 | ||
| 2022-03-31 | -$177.21K 10-Q · filed 2023-05-11 | |||
| 2020-06-30 | -$14.00K 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |